ACLY and autoimmune polyendocrinopathy: Seronegative APS was first defined by Shoenfeld et al. in 2003 as clinical manifestations highly suggestive of APS in the absence of laboratory criteria, such as LAC, aCL, and B2GP1 Abs [8].